Australia markets closed

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.14-0.51 (-4.74%)
At close: 04:00PM EDT
10.37 +0.23 (+2.27%)
After hours: 05:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.00B
Enterprise value 3.21B
Trailing P/E N/A
Forward P/E 72.99
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.14
Price/book (mrq)22.98
Enterprise value/revenue 7.58
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.73
52-week change 3-21.58%
S&P500 52-week change 323.76%
52-week high 314.57
52-week low 39.02
50-day moving average 310.23
200-day moving average 311.66

Share statistics

Avg vol (3-month) 32.51M
Avg vol (10-day) 31.92M
Shares outstanding 5296.2M
Implied shares outstanding 6296.2M
Float 8238.48M
% held by insiders 10.75%
% held by institutions 1109.42%
Shares short (15 May 2024) 428.91M
Short ratio (15 May 2024) 49.78
Short % of float (15 May 2024) 49.82%
Short % of shares outstanding (15 May 2024) 49.76%
Shares short (prior month 15 Apr 2024) 431.32M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -34.73%
Operating margin (ttm)-19.63%

Management effectiveness

Return on assets (ttm)-5.08%
Return on equity (ttm)-126.10%

Income statement

Revenue (ttm)423.49M
Revenue per share (ttm)1.42
Quarterly revenue growth (yoy)28.00%
Gross profit (ttm)N/A
EBITDA -49.02M
Net income avi to common (ttm)-147.07M
Diluted EPS (ttm)-0.49
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)239.6M
Total cash per share (mrq)0.81
Total debt (mrq)444.49M
Total debt/equity (mrq)340.10%
Current ratio (mrq)3.04
Book value per share (mrq)0.44

Cash flow statement

Operating cash flow (ttm)-80.72M
Levered free cash flow (ttm)-37.5M